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Background
Data from the RV144 HIV vaccine trial showed a moder-
ate protection from HIV infection in the absence of neu-
tralizing antibodies or CTL activity. In contrast, all
vaccinees mounted robust HIV-specific binding antibo-
dies, that may have provided some level of protection
through their capacity to recruit antibody dependent cellu-
lar cytotoxicity (ADCC). The capacity of an antibody to
recruit ADCC relies on its ability to interact with the
Fc-receptor, FCgRIII (CD16), expressed on Natural Killer
(NK) cells. However, little is known about innate immune
effector cells present within mucosa, and whether they
have the capacity to be harnessed by ADCC inducing anti-
bodies should they be elicited by a vaccine. Here we
hypothesized that abundant numbers of CD16+ NK cells
line the gut mucosa, providing a robust effector arm that
could be harnessed by ADCC inducing antibodies.
Methods
The frequency and function of CD16+ cells in the colon
was assessed by flow cytometry following enzymatic
digestion of intestinal resections from HIV-uninfected
subjects.
Results
Significantly fewer NK cells were found in colon resections
compared to peripheral blood of healthy controls (median:
10.40% vs. 18.80%, p=0.0062, respectively). Furthermore,
while both CD56bright immunoregulatory and CD56dim
cytolytic NK cells able to mediate ADCC were present in
the gut, the frequency of these 2 subsets was altered com-
pared to the blood. Moreover, fewer NK cells expressed
NKp46, NKG2A, KIR, CD8, perforin, and importantly
CD16 in the gut compared to the blood. However, gut NK
cells demonstrated similar to blood cytolytic activity upon
stimulation.
Conclusion
Taken together, these data suggest that ADCC inducing
antibodies present within the gut mucosa may likely
recruit the antiviral activities of NK cells. Greater empha-
sis should be placed on developing innate immune
recruiting antibody assays that measure the capacity of
antibodies to recruit the antiviral activity of innate
immune cells present within mucosal membranes where
transmission occurs.
Author details
1Ghent University, Ghent, Belgium. 2Ragon Institute, USA, Charlestown, MA,
USA.
Published: 13 September 2012
doi:10.1186/1742-4690-9-S2-P188
Cite this article as: Sips et al.: Natural Killer cells present in gut mucosa
as potential ADCC effector cells. Retrovirology 2012 9(Suppl 2):P188.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1Ghent University, Ghent, Belgium
Full list of author information is available at the end of the article
Sips et al. Retrovirology 2012, 9(Suppl 2):P188
http://www.retrovirology.com/content/9/S2/P188
© 2012 Sips et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
